Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, ...
UAE’s sweeping new banking law introduces criminal penalties for unlicensed crypto tools, raising fears of a de facto ban on ...
Colts RB Jonathan Taylor, rookie TE Tyler Warren and coach Shane Steichen are contenders for some of the NFL's highest honors ...
And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...
NEW YORK, Nov. 14, 2025 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback